The Food and Drug Administration (FDA) on March 17 published a final guidance on reprocessing reusable medical devices. This guidance, which provides manufacturers with recommendations to validate their reprocessing instructions, comes on the heels of a host of “superbug” bacteria outbreaks related to reprocessing of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes.
Imagine completely eliminating surgical site infections (SSIs) without significantly disrupting…
The poster presentations at the 2024 OR Manager Conference showcased…
The poster presentations at the 2024 OR Manager Conference showcased…